Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NSE - Free Realtime Quote INR

Bliss GVS Pharma Limited (BLISSGVS.NS)

Compare
122.11
-3.99
(-3.16%)
As of 11:30:37 AM GMT+5:30. Market Open.
Loading Chart for BLISSGVS.NS
  • Previous Close 126.10
  • Open 126.89
  • Bid 122.00 x --
  • Ask 122.23 x --
  • Day's Range 119.61 - 128.00
  • 52 Week Range 92.15 - 185.50
  • Volume 197,876
  • Avg. Volume 680,547
  • Market Cap (intraday) 12.867B
  • Beta (5Y Monthly) 0.86
  • PE Ratio (TTM) 21.69
  • EPS (TTM) 5.63
  • Earnings Date Apr 30, 2025 - May 5, 2025
  • Forward Dividend & Yield 0.50 (0.42%)
  • Ex-Dividend Date Jul 19, 2024
  • 1y Target Est --

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, soaps, sprays, and vaginal washes. In addition, the company offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

www.blissgvs.com

831

Full Time Employees

March 31

Fiscal Year Ends

Recent News: BLISSGVS.NS

View More

Performance Overview: BLISSGVS.NS

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

BLISSGVS.NS
25.86%
S&P BSE SENSEX (^BSESN)
3.18%

1-Year Return

BLISSGVS.NS
4.12%
S&P BSE SENSEX (^BSESN)
1.92%

3-Year Return

BLISSGVS.NS
57.81%
S&P BSE SENSEX (^BSESN)
24.82%

5-Year Return

BLISSGVS.NS
25.25%
S&P BSE SENSEX (^BSESN)
174.20%

Compare To: BLISSGVS.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BLISSGVS.NS

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    12.64B

  • Enterprise Value

    11.26B

  • Trailing P/E

    21.33

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.58

  • Price/Book (mrq)

    1.25

  • Enterprise Value/Revenue

    1.40

  • Enterprise Value/EBITDA

    8.44

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.36%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    8.1B

  • Net Income Avi to Common (ttm)

    596.12M

  • Diluted EPS (ttm)

    5.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.2B

  • Total Debt/Equity (mrq)

    8.99%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BLISSGVS.NS

View More

Company Insights: BLISSGVS.NS

Research Reports: BLISSGVS.NS

View More

People Also Watch